G1 Therapeutics, Inc.

NasdaqGS:GTHX 株式レポート

時価総額:US$378.2m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

G1 Therapeutics 所有権

大株主は誰で、インサイダーは売買しているのか?


最近のインサイダー取引

NasdaqGS:GTHX 企業または個人による最近のインサイダー取引
日付価値名称エンティティ役割株式最高価格
05 Jul 24SellUS$1,322John UmsteadIndividual527US$2.51
05 Jul 24SellUS$6,207Rajesh MalikIndividual2,475US$2.51
05 Jul 24SellUS$6,207Terry MurdockIndividual2,475US$2.51
05 Jul 24SellUS$19,214John BaileyIndividual7,662US$2.51
05 Jul 24SellUS$6,615Mark AvaglianoIndividual2,638US$2.51
05 Jul 24SellUS$3,353Andrew PerryIndividual1,337US$2.51
23 May 24SellUS$24,864Monica ThomasIndividual5,826US$4.27
13 May 24SellUS$178,421John BaileyIndividual37,258US$4.79
13 May 24SellUS$39,034Terry MurdockIndividual8,151US$4.79
13 May 24SellUS$39,034John UmsteadIndividual8,151US$4.79
13 May 24SellUS$39,034Andrew PerryIndividual8,151US$4.79
13 May 24SellUS$39,034Mark AvaglianoIndividual8,151US$4.79
13 May 24SellUS$39,034Rajesh MalikIndividual8,151US$4.79
18 Mar 24SellUS$19,752John UmsteadIndividual6,547US$3.02
04 Jan 24SellUS$327John UmsteadIndividual111US$2.94
04 Jan 24SellUS$2,121Terry MurdockIndividual721US$2.94
04 Jan 24SellUS$2,121Mark AvaglianoIndividual721US$2.94
04 Jan 24SellUS$2,121Rajesh MalikIndividual721US$2.94
03 Jan 24SellUS$36,447John BaileyIndividual11,686US$3.12
03 Jan 24SellUS$1,971John UmsteadIndividual632US$3.12
03 Jan 24SellUS$9,416Terry MurdockIndividual3,019US$3.12
03 Jan 24SellUS$10,480Mark AvaglianoIndividual3,360US$3.12
03 Jan 24SellUS$7,526Andrew PerryIndividual2,413US$3.12
03 Jan 24SellUS$9,416Rajesh MalikIndividual3,019US$3.12
02 Jan 24SellUS$108,006John BaileyIndividual32,983US$3.27

インサイダー取引量

インサイダー購入: GTHX インサイダー は過去 3 か月間に株式を売却しただけです。


所有権の内訳

GTHX の所有者構成は?
オーナータイプ株式数所有比率
個人インサイダー1,292,7782.44%
ヘッジファンド5,179,5299.79%
VC/PEファーム7,166,70413.6%
一般市民19,030,36936%
機関20,220,99538.2%

株式の希薄化: 過去1年間で株主は希薄化し、発行済み株式総数は2.2%増加しました。


上位株主

25 上位株主56.42 %を所有。
所有権名称株式現在の価値変化率ポートフォリオ
9.79%
Beryl Capital Management LLC
5,179,529US$37.0m0%7.87%
7.97%
Eshelman Ventures, LLC
4,216,074US$30.1m0%100.0%
5.83%
BlackRock, Inc.
3,082,031US$22.0m359%データなし
5.58%
MedImmune Ventures, Inc.
2,950,630US$21.1m0%100.0%
4.71%
The Vanguard Group, Inc.
2,491,109US$17.8m19.7%データなし
2.58%
Woodline Partners LP
1,362,354US$9.7m0%0.09%
2.35%
Renaissance Technologies LLC
1,245,180US$8.9m37.8%0.01%
2.04%
Geode Capital Management, LLC
1,079,645US$7.7m113%データなし
1.75%
Acadian Asset Management LLC
928,205US$6.6m114%0.02%
1.57%
State Street Global Advisors, Inc.
827,956US$5.9m414%データなし
1.51%
Qube Research & Technologies Ltd
800,511US$5.7m147%0.01%
1.51%
Raymond James Financial Inc., Asset Management Arm
797,677US$5.7m-0.64%データなし
1.45%
D. E. Shaw & Co., L.P.
767,066US$5.5m-2.32%0.01%
1.09%
Connor, Clark & Lunn Investment Management Ltd.
576,354US$4.1m39.4%0.02%
1.04%
Fredric Eshelman
550,000US$3.9m0%データなし
0.88%
Jacobs Levy Equity Management Inc
463,593US$3.3m22.7%0.01%
0.8%
abrdn plc
423,869US$3.0m0%データなし
0.75%
Bridgeway Capital Management, LLC
398,043US$2.8m108%0.05%
0.74%
Morgan Stanley, Investment Banking and Brokerage Investments
392,184US$2.8m124%データなし
0.58%
Two Sigma Investments, LP
308,825US$2.2m-7.57%0.01%
0.4%
Two Sigma Advisers, LP
211,700US$1.5m15.2%データなし
0.38%
Eversept Partners, L.P.
199,963US$1.4m0%0.1%
0.38%
Readystate Asset Management LP
199,358US$1.4m0%0.12%
0.37%
John Bailey
196,287US$1.4m4.35%データなし
0.36%
STRS Ohio
192,700US$1.4m0%0.01%